查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030324

數位疫苗市場－全球產業規模、佔有率、趨勢、機會和預測：按設備類型、應用、地區和競爭格局分類，2021-2031年

Digital Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Device Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球數位疫苗市場預計將從 2025 年的 22.1 億美元成長到 2031 年的 35.5 億美元，複合年成長率為 8.22%。

數位疫苗是指透過智慧型手機、平板電腦和穿戴式裝置等數位平台提供的軟體主導介入措施，旨在透過影響神經認知和行為路徑來調節免疫反應並促進更健康的生活習慣，從而預防或緩解健康問題。這一市場成長的主要驅動力是慢性病和感染疾病的日益普遍，這使得人們對便捷的預防性醫療保健解決方案的需求迫切。此外，數位疫苗提供數據驅動的客製化治療，符合個人化醫療的概念，而全球對個人化醫療日益成長的需求也成為推動數位疫苗市場發展的重要因素。

市場概覽
預測期 2027-2031
市場規模：2025年 22.1億美元
市場規模：2031年 35.5億美元
複合年成長率：2026-2031年 8.22%
成長最快的細分市場 智慧型手機
最大的市場 北美洲

另一方面，市場成長的一大障礙是缺乏專門針對數位疫苗的明確法規結構。這種監管上的模糊性和因司法管轄區而異的複雜核准程序導致產品分類混亂，造成市場准入延遲、研發成本飆升和資金籌措障礙，最終限制了其廣泛的市場接受度。同時，產業網路Surescripts報告稱，到2025年，醫療數據交換的數量將達到305億次，這凸顯了支撐醫療保健服務進步的龐大數位基礎設施和活動的必要性。

市場促進因素

數位健康技術的進步是全球數位疫苗市場發展的重要驅動力。人工智慧、數據分析和機器學習領域的突破性進展正在推動高度先進且個人化的數位干預措施的開發。這些技術能夠利用個別患者數據動態調整治療方案，進而提高數位疫苗的有效性和使用者參與度。例如，人工智慧平台可以評估生理反應和行為習慣，以最佳化治療路徑。 Rock Health 在 2026 年 1 月發布的 BioPharma Dive 報告《人工智慧驅動的數位健康資金籌措將在 2025 年擴大：報告》中強調了這一投資趨勢，指出擁有人工智慧能力的公司在 2025 年獲得了 54% 的數位健康資金籌措。這筆資金的湧入直接促進了研發工作，而研發對於建立尖端數位疫苗解決方案至關重要。

此外，新冠疫情後迅速推進的數位轉型對市場產生了重大影響，創造了一個增強人們對數位醫療工具信任和依賴的環境。疫情迫使遠端醫療迅速發展，促使醫療專業人員和消費者廣泛採用數位平台。這種轉變使得智慧型手機和穿戴式裝置在健康管理中的應用變得司空見慣，為數位疫苗的推出創造了有利條件。 Applause 於 2026 年 2 月發表的報導《定義 2026 年醫療保健的四大數字健康趨勢》的文章指出，53% 的美國人擁有穿戴式設備，凸顯了已有大量消費者在使用個人健康科技。此外，對這一不斷發展的生態系統的整體投資仍然強勁。根據 Rock Health 於 2026 年 4 月報道，2026 年第一季，數位健康新創公司透過 110 筆交易籌集了 40 億美元。這種強勁的資金籌措環境反映了數位健康領域的持續成長和創新，間接支持了數位疫苗市場的擴張。

市場挑戰

全球數位疫苗市場擴張面臨的主要障礙之一是缺乏專門針對此類新型干涉措施的明確法律規範。缺乏明確的指導方針導致不同司法管轄區對產品分類有相當大的模糊性。這種不不確定性常常使研發過程複雜化，延長監管審查流程，並延緩數位疫苗的商業化。這直接限制了市場滲透率，並縮小了患者獲得這些預防性醫療保健解決方案的機會。

此外，監管的不確定性推高了這一新興領域企業的研發成本，因為它們必須在缺乏明確藍圖的情況下適應不斷變化且不一致的規則。這樣的環境可能會阻礙數位疫苗技術研發和規模化所需的關鍵投資。例如，產業協會AdvaMed在2025年報告稱，其遊說工作促成了診斷設備產業成員公司每年高達1,550萬美元的報銷調整，這反映了政策環境不明朗對整個醫療技術領域造成的財務影響。此類財務負擔和不穩定的監管環境最終將阻礙數位疫苗技術的廣泛市場應用，並減緩全球數位疫苗市場的成長速度。

市場趨勢

一個顯著的市場趨勢是，數位疫苗正日益融入更廣泛的數位治療生態系統。這一趨勢超越了單一產品的開發。這種融合使數位疫苗能夠利用現有的數位醫療基礎設施、分銷管道和監管路徑，從而加速市場滲透和普及。將這些干預措施定位為綜合數位醫療策略的一部分，可以產生協同效應，使數位疫苗能夠與現有的預防醫學和慢性病管理數位解決方案相輔相成。為了反映這一協調轉變，美國醫院協會 (AHA) 在 2025 年 7 月發表的報導《CMS 宣布新的互通性舉措》中指出，已有 60 多家公司承諾在 2026 年第一季實現聯合成果。這表明各方都致力於在更廣泛的數位醫療生態系統中進行整合，以支援數位疫苗的部署。

另一個重要趨勢是數位疫苗認證系統的擴展。雖然這些系統本身並非數位疫苗，但它們透過為疫苗接種數據創建安全檢驗的框架，顯著提高了數位疫苗的市場可行性。這些系統能夠建立信任並簡化公共衛生運作，從而為包括新型數位方法在內的所有疫苗接種方法的接受和推廣創造更有利的環境。透過標準化數位疫苗認證，這些平台可以提高全球醫療記錄的互通性，並支持國際衛生舉措。歐盟委員會在其2026年3月發布的「國際合作—公共衛生」頁面上強調了這些發展，指出「全球數位健康認證網路」簡化了數位健康證書的共用和檢驗，連接了80多個國家，顯著提高了全球衛生數據交換的效率。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球數位疫苗市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按設備（智慧型手機、平板電腦、其他）
    • 依應用領域（糖尿病、感染疾病、心血管疾病等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美數位疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲數位疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區數位疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲數位疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲數位疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球數位疫苗市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • SANOFI WINTHROP INDUSTRIE
  • GSK Plc.
  • Novavax Inc
  • BioNTech SE
  • Bharat Biotech International Limited
  • Klein Buendel, Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 12817

The Global Digital Vaccine Market is anticipated to expand from USD 2.21 Billion in 2025 to USD 3.55 Billion by 2031, reflecting an 8.22% CAGR. A digital vaccine is a software-driven intervention accessed through digital platforms like smartphones, tablets, and wearables, intended to prevent or reduce health issues by engaging neurocognitive and behavioral pathways to adjust immune responses or encourage healthier habits. This market's growth is primarily fueled by the growing prevalence of chronic and infectious illnesses, which drives the urgent demand for accessible, preventive healthcare solutions. Additionally, the rising global need for personalized medicine acts as a major catalyst, since digital vaccines provide customized, data-informed treatments that align with individualized medical approaches.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.21 Billion
Market Size 2031USD 3.55 Billion
CAGR 2026-20318.22%
Fastest Growing SegmentSmartphones
Largest MarketNorth America

Conversely, a major hurdle to market growth is the lack of clear regulatory frameworks designed specifically for digital vaccines. This regulatory ambiguity and the complicated authorization procedures in different jurisdictions create confusion regarding product categorization, which can delay market entry, drive up development expenses, and discourage financial investments, thereby restricting broader market acceptance. Meanwhile, underscoring the vast digital infrastructure and activity supporting healthcare delivery advancements, the industry network Surescripts reported that health data exchanges reached 30.5 billion in 2025.

Market Driver

Progress in digital health technologies serves as a foundational catalyst for the Global Digital Vaccine Market. Breakthroughs in artificial intelligence, data analytics, and machine learning facilitate the creation of highly advanced and customized digital interventions. Such technologies permit dynamic modifications to treatment plans using individual patient data, thereby improving the effectiveness and user engagement potential of digital vaccines. For instance, AI-driven platforms can assess physiological reactions and behavioral habits to refine therapeutic pathways. Highlighting this investment, Rock Health noted in a January 2026 report covered by BioPharma Dive titled 'Digital health funding increases in 2025, spurred by AI: report' that companies featuring AI capabilities secured 54% of total digital health funding in 2025. This capital influx directly fuels the essential research and development required to build cutting-edge digital vaccine solutions.

Furthermore, the rapid shift toward digitalization following the COVID-19 pandemic has profoundly impacted the market by cultivating an environment of increased trust and reliance on digital healthcare tools. The pandemic forced a quick transition to remote care delivery, resulting in broad adoption of digital platforms by medical professionals and consumers. This shift has normalized using smartphones and wearables for health tracking, establishing fertile ground for deploying digital vaccines. An Applause article from February 2026 titled '4 Digital Health Trends That Will Define Healthcare in 2026' noted that 53% of Americans possess a wearable device, highlighting a substantial consumer base already utilizing personal health technology. Additionally, overall investment within this evolving ecosystem remains strong, as Rock Health reported in April 2026 that digital health startups secured USD 4 billion across 110 transactions in the first quarter of 2026. This robust funding environment signals continuous growth and innovation within the wider digital health sector, indirectly supporting the expansion of the digital vaccine market.

Market Challenge

A major obstacle hindering the expansion of the Global Digital Vaccine Market is the lack of explicit regulatory structures designed specifically for these novel interventions. Without defined guidelines, there is considerable ambiguity regarding product classification across different jurisdictions. Such uncertainty complicates the development pathway, frequently leading to extended regulatory review processes and postponing the commercialization of digital vaccines. This directly restricts market penetration and limits patient access to these preventive healthcare solutions.

Moreover, this regulatory ambiguity drives up development expenses for companies in this emerging sector, as they must navigate changing and inconsistent rules without a clear roadmap. This environment can deter the crucial investments required for researching, developing, and scaling digital vaccine technologies. Demonstrating the financial consequences of unclear policy landscapes on the broader medical technology sector, the industry association AdvaMed reported in 2025 that their advocacy efforts achieved a landmark reimbursement correction valued at up to USD 15.5 million annually for diagnostic members. This type of financial strain and unstable regulatory atmosphere ultimately restricts broader market adoption and slows the growth trajectory of the Global Digital Vaccine Market.

Market Trends

A notable market trend is the increasing integration of digital vaccines into wider digital therapeutic ecosystems, a movement that extends beyond individual product development. This integration enables digital vaccines to utilize established digital health infrastructure, distribution channels, and regulatory pathways, thereby accelerating their market penetration and adoption. By positioning these interventions as components of a comprehensive digital health strategy, synergistic effects emerge, allowing digital vaccines to complement current digital solutions for preventive care or chronic disease management. Reflecting this collaborative shift, the American Hospital Association noted in a July 2025 article titled 'CMS announces new interoperability initiative' that over 60 companies committed to delivering joint results in the first quarter of 2026, demonstrating a widespread dedication to integrating within a broader digital health ecosystem that aids digital vaccine deployment.

Another crucial trend is the expansion of digital vaccination credential systems, which, despite not being digital vaccines themselves, significantly boost their market viability by creating a secure and verifiable framework for immunization data. These systems build trust and streamline public health operations, fostering a more robust environment for the acceptance and rollout of all vaccination modalities, including new digital approaches. By standardizing digital proofs of vaccination, these platforms can improve the global interoperability of medical records and support international health initiatives. Emphasizing this progress, the European Commission stated on its March 2026 'International Cooperation - Public Health' page that the Global Digital Health Certification Network, which streamlines the sharing and verification of digital health certificates, has connected over 80 countries, making global health data exchange much more efficient.

Key Market Players

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • SANOFI WINTHROP INDUSTRIE
  • GSK Plc.
  • Novavax Inc
  • BioNTech SE
  • Bharat Biotech International Limited
  • Klein Buendel, Inc

Report Scope

In this report, the Global Digital Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Vaccine Market, By Device Type

  • Smartphones
  • Tablets
  • Others

Digital Vaccine Market, By Application

  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Digital Vaccine Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Vaccine Market.

Available Customizations:

Global Digital Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Vaccine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (Smartphones, Tablets, Others)
    • 5.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Digital Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Vaccine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Digital Vaccine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Digital Vaccine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By Application

7. Europe Digital Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Digital Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Digital Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Digital Vaccine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Digital Vaccine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Digital Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Digital Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Digital Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Digital Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Digital Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Digital Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Digital Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Digital Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Digital Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Digital Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Application

10. South America Digital Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Digital Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Digital Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Digital Vaccine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Pfizer Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Moderna, Inc
  • 15.3. AstraZeneca Plc
  • 15.4. Johnson & Johnson Service Inc.
  • 15.5. SANOFI WINTHROP INDUSTRIE
  • 15.6. GSK Plc.
  • 15.7. Novavax Inc
  • 15.8. BioNTech SE
  • 15.9. Bharat Biotech International Limited
  • 15.10. Klein Buendel, Inc

16. Strategic Recommendations

17. About Us & Disclaimer